Vitaxin
Vitaxin
Vitaxin (pronounced vih-TAX-in) is a monoclonal antibody that is being studied in the treatment of certain types of cancer. It is a type of angiogenesis inhibitor.
Pronunciation
The pronunciation of Vitaxin is "vih-TAX-in".
Etymology
The term Vitaxin is derived from the Latin word 'vita' meaning life and 'xin' from toxin, indicating its role in inhibiting harmful substances in the body.
Function
Vitaxin works by binding to a protein called integrin, which is found on the surface of new blood vessels and some types of cancer cells. By binding to integrin, Vitaxin can block the growth of new blood vessels that tumors need to grow and spread. This makes it a type of angiogenesis inhibitor.
Related Terms
- Monoclonal antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
- Angiogenesis inhibitor: A substance that may prevent the formation of blood vessels. In anticancer therapy, an angiogenesis inhibitor prevents the growth of new blood vessels that tumors need to grow.
- Integrin: A family of proteins that are involved in cell adhesion and cell-surface mediated signaling.
Clinical Trials
Vitaxin has been studied in clinical trials for the treatment of melanoma, rheumatoid arthritis, and other conditions. However, as of now, it is not yet approved by the Food and Drug Administration (FDA) for any specific medical use.
See Also
External links
- Medical encyclopedia article on Vitaxin
- Wikipedia's article - Vitaxin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski